Study of Intravenous Ceftolozane/Tazobactam Compared to Piperacillin/Tazobactam in Ventilator-Associated Pneumonia
Status:
Terminated
Trial end date:
2013-12-08
Target enrollment:
Participant gender:
Summary
This is a Phase 3, multicenter, prospective, randomized, open-label, study to compare the
safety and efficacy of intravenous (IV) ceftolozane/tazobactam with that of IV
piperacillin/tazobactam in the treatment of ventilator-associated pneumonia (VAP) in adult
participants .
Phase:
Phase 3
Details
Lead Sponsor:
Cubist Pharmaceuticals LLC
Treatments:
Ceftolozane Ceftolozane, tazobactam drug combination Cephalosporins Penicillanic Acid Piperacillin Piperacillin, Tazobactam Drug Combination Tazobactam